From the Journals

Review: Common gastrointestinal conditions in people living with HIV/AIDS


 

FROM CRITICAL CARE NURSING CLINICS OF NORTH AMERICA

The two most common gastrointestinal conditions reported by people living with HIV/AIDS are diarrhea and nausea, according to Vincent Hall, PhD.

Diarrhea has been reported in up to 60% of people living with HIV/AIDS, and is generally classified as being infectious or noninfectious. While infectious causes of diarrhea, such as bacteria, fungi, viruses, and protozoa, have declined, noninfectious causes have increased. Common causes of noninfectious diarrhea include HIV enteropathy, diarrhea associated with highly active antiretroviral therapy (HAART), autonomic neuropathy, and chronic pancreatitis.

Prior to the development of HAART, nausea in people living with HIV/AIDS was usually caused by opportunistic infections; however, this has changed. Nausea can come from medication side effects, overlapping drug interactions, and from opportunistic infections in patients with poor immune health. The most common side effect of ART is nausea, and nausea is also the most common cause of ART discontinuation.

“It has been noted that HIV infection can be considered a disease of the GI tract because it is a significant target of infection and because of the side effects HAART can have on the GI system. Therefore, it is important that clinicians have an understanding of the causes of diarrhea and nausea and vomiting in people living with HIV/AIDS and educate patients about potential side effects and treatment options,” Mr. Hall concluded.

Find the full review in Critical Care Nursing Clinics of North America (doi: 10.1016/j.cnc.2017.10.009).

Recommended Reading

Statin didn’t slow hepatic steatosis in HIV patients
MDedge Infectious Disease
Delayed HIV diagnoses still substantial for some at-risk groups
MDedge Infectious Disease
Viral failure lower in dolutegravir treated HIV patients
MDedge Infectious Disease
Long-acting injectable PrEP trial launched in Africa
MDedge Infectious Disease
Denmark reinstates ID NAT screening for blood donations
MDedge Infectious Disease
New HIV vaccine trial launched in Africa
MDedge Infectious Disease
Preexposure prophylaxis among LGBT youth
MDedge Infectious Disease
FDA approves raltegravir for newborns at risk for HIV-1 infection
MDedge Infectious Disease
Teens with PID underscreened for HIV, syphilis
MDedge Infectious Disease
CMV colitis mortality rates similar in both immunocompetent and immunocompromised patients
MDedge Infectious Disease